Company Statement: Bristol-Myers Squibb Proposes to Acquire ImClone Systems for $60.00 Per Share in Cash
****************************************Offer Represents Approximately 30% Premium to the Closing Price of ImClone’s Stock on July 30, Approximately 40% Premium to the Average Share Price of ImClone Common Stock During the Most Recent...To view the full article, register now.
Already a subscriber? Click here to view full article